“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database
Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.
New clinical trials added on Oct 30, 2023
Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer
NCT Number : NCT06097546
Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema
NCT Number : NCT06095323
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer
NCT Number : NCT06091943
Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery
NCT Number : NCT06094621
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
NCT Number : NCT06097416
The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer
NCT Number : NCT06092242
ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study
NCT Number : NCT06095674
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
NCT Number : NCT06094842
Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
NCT Number : NCT06096870
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment
NCT Number : NCT06096623
Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
NCT Number : NCT06096844
cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis
NCT Number : NCT06098248
Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer
NCT Number : NCT06097078
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
NCT Number : NCT06095089
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
NCT Number : NCT06091930
A Study of HY-0102 in Patients With Advanced Solid Tumors
NCT Number : NCT06094777
INvestigating DIGital Outcomes in the Community
NCT Number : NCT06095024
A Study to Assess Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT Number : NCT06095583
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
NCT Number : NCT06095505
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
NCT Number : NCT06092892
Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery
NCT Number : NCT06095882
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
NCT Number : NCT06096038
Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications
NCT Number : NCT06097156
Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein
NCT Number : NCT06093503
Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study
NCT Number : NCT06098404
Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS
NCT Number : NCT06096974
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
NCT Number : NCT06095141
Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS
NCT Number : NCT06098118
Axillary Management After Neoadjuvant Chemotherapy
NCT Number : NCT06096545
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
NCT Number : NCT06094296
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
NCT Number : NCT06092047
A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors
NCT Number : NCT06092268
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors
NCT Number : NCT06094556
Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer
NCT Number : NCT06094868
Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum
NCT Number : NCT06096493
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
NCT Number : NCT06094985
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
NCT Number : NCT06096688
New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer
NCT Number : NCT06097936
Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
NCT Number : NCT06093438
Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
NCT Number : NCT06093425
NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer
NCT Number : NCT06094140
An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases
NCT Number : NCT06093698
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT Number : NCT06094530
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
NCT Number : NCT06093022
Intraoperative Radiotherapy in Treating Spinal Metastases
NCT Number : NCT06093854
Phase 1 Study of AWT020 in Advanced Cancer
NCT Number : NCT06092580
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
NCT Number : NCT06093061
Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
NCT Number : NCT06092450
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
NCT Number : NCT06094426
A Biomarker Study for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
NCT Number : NCT06098560
A Study of DCR-STAT3 in Adults With Solid Tumors
NCT Number : NCT06098651
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
NCT Number : NCT06092606
RE-irradiation of Diffuse MIdline Glioma paTients
NCT Number : NCT06093165
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy
NCT Number : NCT06093971
Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer
NCT Number : NCT02397434
Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC
NCT Number : NCT06092086
Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects
NCT Number : NCT06093945
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
NCT Number : NCT06095167
Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma
NCT Number : NCT06092645
Improvement of Quality of Life by Cannabinoids in Oncologic Patients
NCT Number : NCT06097533
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
NCT Number : NCT06097468
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis
NCT Number : NCT06096779
A Study of SVZ Irradiation With Postoperative Radiotherapy in Patients With GBM.
NCT Number : NCT06092255
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
NCT Number : NCT06094322
LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma
NCT Number : NCT06098547
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
NCT Number : NCT06094257
New-mode Clinical Target Volume Delineation of Nasopharyngeal Carcinoma
NCT Number : NCT06095154
Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF
NCT Number : NCT06097338
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
NCT Number : NCT06097975
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
NCT Number : NCT06092112
Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa
NCT Number : NCT06094829
Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
NCT Number : NCT06093048
Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy
NCT Number : NCT06092944
A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants
NCT Number : NCT06092931
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
NCT Number : NCT06097728
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT Number : NCT06093867
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza
NCT Number : NCT06094010
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
NCT Number : NCT06092125
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
NCT Number : NCT06092333
Watchful Waiting for Patients With Multifocal Ground-glass Opacities (ECTOP-1021)
NCT Number : NCT06097910
Nourishing the Community Through Culinary Medicine- Acres Homes
NCT Number : NCT06096506
Pulmonary MRI Using Ultra Short /Zero TE Sequences
NCT Number : NCT06097741
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
NCT Number : NCT06095596
Analysis of Urinary, Vaginal and Intestinal Microbiota in Patients With Neurogenic Bladder
NCT Number : NCT06093035
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
NCT Number : NCT06094101
Culturally Tailored HPV Psychoeducational Multimedia Intervention
NCT Number : NCT06098690
Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD
NCT Number : NCT06093334
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
NCT Number : NCT06096896
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT Number : NCT06092957
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
NCT Number : NCT06097832
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
NCT Number : NCT06092879
Safety and Efficacy of NK510 to Treat NSCLC
NCT Number : NCT06097962
Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment
NCT Number : NCT06095934
Relmacabtagene Autoleucel as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL
NCT Number : NCT06093841
The Effect of Bilateral Rectus Sheath Block Versus Wound Infiltration in Gynecooncological Patients
NCT Number : NCT06095908
Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection
NCT Number : NCT06096948
A Study to Learn How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Compared to Rituximab and Chemotherapy in Adult Participants With Previously Untreated Follicular Lymphoma
NCT Number : NCT06097364
Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia
NCT Number : NCT06098014
First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma
NCT Number : NCT06097455
Multiple Myeloma Prognostic Indices
NCT Number : NCT06095752
Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1
NCT Number : NCT06094894
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
NCT Number : NCT06098430
Delving Into Participation Trends in Renal Cell Carcinoma Studies
NCT Number : NCT06093568
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
NCT Number : NCT06097793
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
NCT Number : NCT06093672
HCT With PTCy in Higher-risk MDS
NCT Number : NCT06098313
CyFluATG in Lower Risk MDS
NCT Number : NCT06098326
Chronic Cancer Pain Management Program
NCT Number : NCT06101849
Breast Cancer Resiliency Through Exercise Program (B-REP)
NCT Number : NCT06100263
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After progrEssion on ENhertu (SATEEN)
NCT Number : NCT06100874
Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)
NCT Number : NCT06102161
Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy
NCT Number : NCT06099951
eHealth Interventions for Breast Cancer Cognitive Impairment
NCT Number : NCT06103318
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT Number : NCT06099093
BCG for Therapeutic Use Phase I Clinical Trial
NCT Number : NCT06100653
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
NCT Number : NCT06101966
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
NCT Number : NCT06102824
Development of MRF for Characterization of Brain Tumors After Radiotherapy
NCT Number : NCT06101069
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
NCT Number : NCT06102902
ASCENT Intervention for Brain Tumor Patients
NCT Number : NCT06099743
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
NCT Number : NCT06100705
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
NCT Number : NCT06099418
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
NCT Number : NCT06100328
Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.
NCT Number : NCT06099119
Development of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules
NCT Number : NCT06101394
The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients
NCT Number : NCT06102707
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
NCT Number : NCT06099990
Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study
NCT Number : NCT06102876
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With HER2+ Locally Advanced and/ or Metastatic Solid Tumors
NCT Number : NCT06101082
Prophylactic Oral Vitamin D and Zinc for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NCT Number : NCT06100692
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)
NCT Number : NCT06099782
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
NCT Number : NCT06103279
The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies
NCT Number : NCT06099925
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
NCT Number : NCT06099821
Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck
NCT Number : NCT06100081
Fruquintinib Combined With TAS102 for Advanced Gastric Cancer
NCT Number : NCT06102785
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
NCT Number : NCT06100718
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT Number : NCT06099769
HOBBIT 3: Mental Exercises and Temporal Alteration
NCT Number : NCT06100068
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer
NCT Number : NCT06102772
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
NCT Number : NCT06102759
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
NCT Number : NCT06102018
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
NCT Number : NCT06104371
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
NCT Number : NCT06104618
Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma
NCT Number : NCT06102447
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
NCT Number : NCT06104085
Qualitative Techniques to Define Meaningful Within-Patient Change in Symptoms of Advanced Cancer Patients
NCT Number : NCT06104657
Medical Tai Chi Exercise Healing in Treating mCRC Patients
NCT Number : NCT06104267
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
NCT Number : NCT06104774
PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy
NCT Number : NCT06101043
A Study of Avutometinib for People With Solid Tumor Cancers
NCT Number : NCT06104488
Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD
NCT Number : NCT06092281
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
NCT Number : NCT06103682
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
NCT Number : NCT06103669
Tumor Vaccines for Solid Tumors
NCT Number : NCT06102837
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NCT Number : NCT06101277
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
NCT Number : NCT06100367
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
NCT Number : NCT06100003
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
NCT Number : NCT06100016
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation
NCT Number : NCT06102928
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
NCT Number : NCT06101290
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as an Adjuvant Treatment in Endometrial Carcinoma
NCT Number : NCT06102252
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
NCT Number : NCT06103916
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
NCT Number : NCT06104241
BGT007H Cells for the Treatment of Refractory Digestive System Tumors
NCT Number : NCT06104215
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT Number : NCT06100497
Teclistamab or Talquetamab in Combination With Daratumumab for High-Risk Smoldering Myeloma (REVIVE Study)
NCT Number : NCT06100237
Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma
NCT Number : NCT06102746
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL
NCT Number : NCT06104592
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
NCT Number : NCT06102525
Immunonutrition in ERAS Protocols in Gynecologic Oncology
NCT Number : NCT06103526
Optimization of Fractionation Schedules of Heel Spur Radiotherapy Prospective Randomized Open-label Trial
NCT Number : NCT06104410
Binaural Sound for Remimazolam Induction
NCT Number : NCT06099977
A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone
NCT Number : NCT06104878
Fruquintinib in the Cross-line Treatment of Refractory mCRC
NCT Number : NCT06099314
Plasma Extracellular Vesicles in Meningioma Patients
NCT Number : NCT06104930
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT Number : NCT06102057
A Study of [14C]-LOXO-783 in Healthy Adult Participants
NCT Number : NCT06102512
Siderophore-labelled Position Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT Number : NCT06105411
EEG Characteristics and Postoperative Delirium
NCT Number : NCT06102967
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
NCT Number : NCT06102213
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
NCT Number : NCT06104553
Feasibility of Using Surplus qFIT Samples to Investigate the Gut Microbiota.
NCT Number : NCT06100549
A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis
NCT Number : NCT06104683
Genetic Susceptibility to Severe Infections
NCT Number : NCT06102070
PFA 100 Evaluation and Reference Interval HOACNY
NCT Number : NCT06100510
Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT Number : NCT06103890
Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography
NCT Number : NCT06099275
Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI
NCT Number : NCT06100796
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
NCT Number : NCT06102395
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
NCT Number : NCT06100744
Dynamic Frailty Assessment for Guiding the Treatment in Older Adults With Newly Diagnosed Multiple Myeloma
NCT Number : NCT06099912
Cohort Study in Fujian Province
NCT Number : NCT06102187
Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction
NCT Number : NCT06101719
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
NCT Number : NCT06101134
Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions
NCT Number : NCT06105606
Immunology of Ebola Vaccine
NCT Number : NCT06100913
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
NCT Number : NCT06105658
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene.
NCT Number : NCT06105619
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
NCT Number : NCT06102863
SIBTime Phase II: Web Application for Typically Developing Siblings
NCT Number : NCT06099457
Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis
NCT Number : NCT06101823
Driving Pressure During General Anesthesia for Minimally Invasive Abdominal Surgery (GENERATOR)
NCT Number : NCT06101511
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
NCT Number : NCT06099366
Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma
NCT Number : NCT06104709
Pilot Study on Trametinib for Surgical Unruptured AVMs
NCT Number : NCT06098872
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
NCT Number : NCT06101381
Ovary Syndrome for Efficient Diagnosis and Targeted Therapy
NCT Number : NCT06102629
Prevalence of ENT Diseseas
NCT Number : NCT06105346
Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
NCT Number : NCT06101147
A Exploratory Trial of WTX212A Injection in the Treatment of Patients With Advanced Lung Cancer
NCT Number : NCT06106152
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT Number : NCT06105177
The Effect of Dignity Therapy Applied to Cancer Patients
NCT Number : NCT06105359
TIL Therapy for Patients With Advanced Solid Tumors
NCT Number : NCT06107894
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer
NCT Number : NCT06105008
Improving Muslim Women's Uptake of Cancer Screening (IMCAN)
NCT Number : NCT06106165
Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer
NCT Number : NCT06105515
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
NCT Number : NCT06108232
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
NCT Number : NCT06105632
Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment
NCT Number : NCT06108089
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
NCT Number : NCT06106360
Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer
NCT Number : NCT06103617
An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions
NCT Number : NCT06106568
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
NCT Number : NCT06107413
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
NCT Number : NCT06105684
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
NCT Number : NCT06107868
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
NCT Number : NCT06106308
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
NCT Number : NCT06106477
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
NCT Number : NCT06107920
RATME vs LATME in Middle and Low Rectal Cancer
NCT Number : NCT06105203
The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).
NCT Number : NCT06106711
A Study of MK-5684 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
NCT Number : NCT06104449
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT Number : NCT06107374
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
NCT Number : NCT06108050
TBNA vs EBUS-TBNA Plus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing
NCT Number : NCT06105801
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT Number : NCT06103864
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer
NCT Number : NCT06105918
A Study of YL202 in Selected Patients With Advanced Solid Tumors
NCT Number : NCT06107686
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
NCT Number : NCT06105021
REDucing Hot FLASHes in Women Using Endocrine Therapy.
NCT Number : NCT06106529
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
NCT Number : NCT06105554
Ketogenic Diet Improves Thrombocytopenia in Cancer Patients
NCT Number : NCT06106139
Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"
NCT Number : NCT06107478
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT Number : NCT06107738
18F-Fluciclovine PET/CT in Multiple Myeloma
NCT Number : NCT06103838
Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
NCT Number : NCT06106802
CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study
NCT Number : NCT06106776
Biennial CEM in Women With a Personal History of Breast Cancer
NCT Number : NCT06105749
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC)
NCT Number : NCT06107673
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)
NCT Number : NCT06106282
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
NCT Number : NCT06107608
Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow
NCT Number : NCT06106997
Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma
NCT Number : NCT06107114
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2)
NCT Number : NCT06106828
Enter a few details below to get started and we'll help you match up with active clinical trials
9200 Trials found
Cancer Details
Eligibility Criteria
Location
OncoPower Clinical Trial Features
Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you
We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria
Our team will connect you with financial resources available to clinical trial participants
OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial
Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.
There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).
Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.
You are able to leave a clinical trial at any time, for any reason.
Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.
Joan-Smith
Virginia, United States
ChuckHastings
Florida, United States
DebraPearl
Pennsylvania, United States
Jennweeks
Iowa , United States
PatrickDW
Western Cape, South Africa
Jamie-Alexander
Floroda United States
CJ
Liz
Florida, United States
NYCynthia
New York, United States
Ferdi
California, United States
Begin offering a comprehensive digital experience for your patients.
Enter your E-mail address to receive your results